(7509626), S. S., (7509629), A. A., (14153268), A. M. A., (7509635), P. T., & (1474849), H. M. K. (2019). Phloretin attenuates STAT-3 activity and overcomes sorafenib resistance targeting SHP-1–mediated inhibition of STAT3 and Akt/VEGFR2 pathway in hepatocellular carcinoma.
Chicago Style (17th ed.) Citation(7509626), Sarita Saraswati, Abdulqader Alhaider (7509629), Abdelgalil Mohamed Abdelgadir (14153268), Pooja Tanwer (7509635), and Hesham M. Korashy (1474849). Phloretin Attenuates STAT-3 Activity and Overcomes Sorafenib Resistance Targeting SHP-1–mediated Inhibition of STAT3 and Akt/VEGFR2 Pathway in Hepatocellular Carcinoma. 2019.
MLA (9th ed.) Citation(7509626), Sarita Saraswati, et al. Phloretin Attenuates STAT-3 Activity and Overcomes Sorafenib Resistance Targeting SHP-1–mediated Inhibition of STAT3 and Akt/VEGFR2 Pathway in Hepatocellular Carcinoma. 2019.